Logos Capital

About Logos Capital

Logos Capital focuses on advancing healthcare through disciplined, data-driven investment in biotechnology. The firm identifies and funds life-changing therapeutics by combining rigorous event tracking, clinical trial underwriting, and proactive risk management to assess intrinsic value and potential returns for investors. With a team drawn from chemistry, engineering, biology, and data science, Logos Capital emphasizes transformative therapies and evidence-based decision making across private and public biotech opportunities. The company operates primarily in the San Francisco Bay Area and aims to drive progress in healthcare by supporting breakthrough innovations in patient care.